The Hong Kong Polytechnic University
Hung Hom, Hong Kong
Location status: Recruiting
NCT Number: NCT05539482
This study evaluates the community-based health education program in improving early testing for COVID-19, increasing vaccination acceptability and enhancing emergency preparedness and self-protection measures against COVID-19 in HK. We established a partnership with several local community stakeholders and they will be responsible for recruiting participants and implementing educational programs. Half of the community collaborators will receive the core intervention package, and use it as education material. The other half will be encouraged to self-collect and send health information to the participants.
Interested in participating?
Request Info12 year and older
All sexes
Interventional
Not applicable
Hung Hom, Hong Kong
Location status: Recruiting
This health education program is based on a Community-based Participants Research (CBPR) approach, which is a partnership approach that equitably involves community members and researchers in all aspects of the research process. Given the different cultural, professional or living background of Hong Kong residents, we think this simple, flexible and sustainable approach will effectively mitigate the COVID-19 risk in HK society,
An academic-community collaboration platform with several nongovernmental organizations (NGOs), companies and schools will be established before this study. They will work together to recruit participants, design and implement a series of educational programs aimed at controlling the spread of COVID-19 in the community.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
For participants recruited by NGOs and companies, the Inclusion Criteria will be:
The Exclusion Criteria will be:
For participants recruited by schools, the Inclusion Criteria will be:
The Exclusion Criteria will be:
Community-based Health Education will potentially include the following three components:
Collaborators should design and implement health programs based on the core intervention package.
Collaborators are encouraged to collect and share health information to the participants. Shared information should be previewed by researchers.
Time frame: 3 months
The number of participants who received a new dose of COVID-19 vaccine over the total number of participants.
Time frame: 3 months
The knowledge towards COVID-19 vaccine will be measured by 15 items in the self-administered questionnaire. All the items are binary- choice Items (1=Ture, 2= False). The total score ranged from 15 to 30 and a higher score indicates poorer knowledge towards COVID-19 vaccine.
Time frame: 3 months
The hesitancy towards COVID-19 vaccine will be measured by Chinese version of adult Vaccine Hesitancy Scale (aVAS), which includes 10 items of 5-point Likert scale, ranging from least hesitant (1) to most hesitant (5). In total 3 of aVAS are negatively worded and 7 are positively worded. The total score of aVAS is 50 with a score higher than 25 indicated high vaccine hesitancy.
Time frame: 3 months
The confidence of COVID-19 vaccine will be measured by 11 items with 5-point Likert scale with "strongly disagree", "disagree", "neither agree nor disagree", "agree" and "strongly agree". The total score ranges from 11 to 55 with higher score indicating higher confidence of COVID-19 vaccine..
Time frame: 3 months
The perceived barriers of COVID-19 vaccine will be measured by 4 items with 5-point Likert scale with "strongly disagree", "disagree", "neither agree nor disagree", "agree" and "strongly agree". The total score ranges from 4 to 20 with higher score indicating higher perceived barriers of COVID-19 vaccine..
Time frame: 3 months
The amount of early testing will be measured by self-reported number of early-testing with rapid antigen testing (RAT) in a month.
Time frame: 3 months
The levels of acceptability for early testing will be measured by 3 items with 5-point Likert scale with "strongly disagree", "disagree", "neither agree nor disagree", "agree" and "strongly agree". The total score ranges from 3 to 15 with higher score indicating higher acceptability of early testing.
Time frame: 3 months
The amount of early testing will be measured by self-reported number of hand-washing behaviors with soap or hand sanitizer per day in the past week.
Time frame: 3 months
The amount of early testing will be measured by self-reported number of hand-washing behaviors with alcohol-based hand rub per day in the past week.
Time frame: 3 months
The knowledge of proper self-protection correctly will be measured 13 items in the self-administered questionnaire. All the items are binary- choice Items (1=Ture, 2= False). The total score ranged from 13 to 26 and a higher score indicates poorer knowledge of self-protection.
Time frame: 3 months
The Perceived Stress Scale (PSS-4) will be used to measure the stress level.
Time frame: 3 months
Generalized Anxiety Disorder (GAD-2) will be used to measure the level of anxiety.
Time frame: 3 months
The Patient Health Questionnaire-2 (PHQ-2) will be used to measure the depression status.
Time frame: 3 months
The participants' satisfactory level will be measured by asking the degree of satisfaction (1-10) in terms of vaccination, early-testing and self-protection.
Contact information is provided by the study sponsor or research team.
The Hong Kong Polytechnic University
Other
A Multicenter, Cluster-Randomized, Active-Controlled, Single-Blind Trial of Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05384561
Anosmia, COVID-19
Trois-Rivières, Quebec, Canada
View Trial DetailsNCT07536308
COVID-19, Coronaviridae Infections
Decatur, Georgia, United States
View Trial DetailsNCT05787327
COVID-19, Coronaviridae Infections
Hong Kong
View Trial DetailsNCT01306084
Adenoviridae Infections, Anogenital Herpes
Bethesda, Maryland, United States
View Trial Details